Related Articles
NJK14013, a novel synthetic estrogen receptor-α agonist, exhibits estrogen receptor-independent, tumor cell-specific cytotoxicity
TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF‑7 cells
Tamoxifen inhibits the proliferation of non‑melanoma skin cancer cells by increasing intracellular calcium concentration
Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells
Associations of retinoids, tamoxifen and alpha-interferon 2a in human breast cancer